A newly published study paves the way for some patients with testicular cancer to avoid chemotherapy and radiation.
Mar 30, 2023
0
16
Despite the recent development of new targeted therapies, chemotherapies remain the most frequently used treatment to treat patients suffering from advanced cancers. Chemotherapy resistance is one of the main causes of treatment ...
Mar 22, 2023
0
61
Among people receiving chemotherapy regimens containing anthracyclines for lymphoma, those who took the cholesterol-lowering drug atorvastatin for one year were significantly less likely to show evidence of heart dysfunction ...
Mar 6, 2023
0
4
Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research led by the Garvan Institute of Medical Research shows.
Mar 3, 2023
0
44
Certain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, according to a new study from University of Pittsburgh and UPMC researchers that may help explain ...
Mar 3, 2023
1
12
Researchers from Imperial College London, the Institute of Cancer Research (ICR) and the Netherlands Cancer Institute, found that the test can predict whether a bowel cancer patient will benefit from chemotherapy. It is thought ...
Mar 2, 2023
0
60
A large team of cancer researchers affiliated with multiple institutions in Germany, working with a colleague from the U.S., has discovered some of the ways gut bacteria can positively impact treatments for cancer. In their ...
When older adults with cancer take multiple medications—including ordinary drugs like blood pressure pills, supplements, or antacids—it can result in more toxic chemotherapy side effects and even a need to stop cancer ...
Feb 27, 2023
0
3
Platinum-based chemotherapy, which is used to treat advanced colorectal cancer, accumulates in the healthy cells surrounding the cancer cells and, as a result, can reduce tumor sensitivity to treatment. This is demonstrated ...
Feb 24, 2023
0
74
Patients with resectable non–small cell lung cancer (NSCLC) who were treated with neoadjuvant nivolumab had improved five-year recurrence-free and overall survival rates compared with historical outcomes, according to results ...
Feb 15, 2023
0
6
